ArticleJournal of the American Heart Association2013

Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction.

Benjamin S Rayner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.